Close Menu

NEW YORK (GenomeWeb) – Cancer Genetics reported on Tuesday that its fourth quarter revenues fell 9 percent year over year, partially due to the impact on its clinical services business unit from the adoption of new revenues recognition standards at the beginning of 2018.

For the three months ended Dec. 31, 2018, the firm reported total revenues of $6.8 million, down from $7.5 million in the fourth quarter of 2017. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.